GlassScriptPhysician profile
Kaitlin Amanda Jones
NPI 1134611320
$20,465.70
in general payments reported to CMS, 2019-2025
72 companies · $4,726 in 2025
The $4,726 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,044 · 2022: $3,901 · 2023: $3,689 · 2024: $5,107 · 2025: $4,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Long Term Medical Supply Or Device Loan: $2,196 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,139.96 |
| Long Term Medical Supply Or Device Loan | $2,196.36 |
| Education | $185.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,408.12 | 2021-2025 | |
| Janssen Biotech, INC. | $994.19 | 2021-2025 | Darzalex, Tecvayli, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $951.76 | 2021-2025 | Calquence, Enhertu, Lynparza |
| Celgene Corporation | $867.93 | 2021-2025 | Reblozyl, Pomalyst, Opdivo |
| Incyte Corporation | $846.71 | 2021-2025 | Monjuvi, Pemazyre, Jakafi |
| E.R. Squibb & Sons, L.L.C. | $814.80 | 2021-2025 | Opdivo, Opdualag, Pomalyst |
| Gilead Sciences, INC. | $704.23 | 2021-2025 | Trodelvy |
| Daiichi Sankyo INC. | $678.83 | 2021-2025 | Enhertu, Datroway |
| Pfizer INC. | $613.36 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $598.36 | 2021-2023 | Imbruvica, Epkinly |
| Abbvie INC. | $585.51 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $579.10 | 2021-2025 | Keytruda, Welireg, Lenvima |
| Regeneron Healthcare Solutions, INC. | $531.89 | 2021-2025 | Libtayo |
| Beigene USA, INC. | $493.62 | 2021-2025 | Brukinsa |
| Genentech USA, INC. | $482.12 | 2021-2025 | Phesgo, Tecentriq, Itovebi |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $472.37 | 2021-2025 | Jaypirca, Verzenio |
| Genzyme Corporation | $450.53 | 2021-2025 | |
| Coherus Oncology, INC. | $423.15 | 2021-2025 | Loqtorzi |
| Eisai INC. | $376.49 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $372.63 | 2021-2025 | Gilotrif |
| Bayer Healthcare Pharmaceuticals INC. | $367.64 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $361.70 | 2021-2025 | Somatuline Depot, Onivyde, Dysport |
| Exelixis INC. | $360.10 | 2021-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $357.31 | 2021-2025 | Xpovio |
| Astellas Pharma US INC | $345.72 | 2021-2025 | Padcev, Vyloy, Xtandi |
| Puma Biotechnology, INC. | $236.93 | 2021-2025 | |
| Amgen INC. | $217.87 | 2021-2025 | Lumakras |
| Emd Serono, INC. | $207.40 | 2021-2025 | Bavencio |
| Morphosys, US INC. | $195.38 | 2021-2024 | Monjuvi |
| Takeda Pharmaceuticals U.S.A., INC. | $193.38 | 2023-2025 | Fruzaqla, Ninlaro, Iclusig |
| Organon LLC | $168.22 | 2021-2024 | Ontruzant |
| Myovant Sciences INC. | $166.66 | 2021-2022 | |
| Sobi, INC | $165.16 | 2022-2025 | |
| Intuitive Surgical, INC. | $130.77 | 2025 | |
| Alexion Pharmaceuticals, INC. | $129.35 | 2023-2024 | Ultomiris |
| Beone Medicines USA, INC. | $115.66 | 2025 | Brukinsa |
| Array Biopharma INC | $88.49 | 2024-2025 | Mektovi, Braftovi, Lorbrena |
| Deciphera Pharmaceuticals INC. | $78.10 | 2021-2025 | Qinlock |
| Stemline Therapeutics INC. | $73.48 | 2024-2025 | Elzonris, Orserdu |
| Seagen INC. | $73.17 | 2022-2023 | Padcev |
| Iovance Biotherapeutics, INC. | $65.20 | 2025 | Amtagvi |
| Kyowa Kirin, INC. | $63.56 | 2023-2025 | Poteligeo |
| Glaxosmithkline, LLC. | $62.75 | 2021-2025 | Ojjaara |
| Aveo Pharmaceuticals, INC. | $62.42 | 2021-2024 | |
| Ge Healthcare | $60.01 | 2025 | |
| Blueprint Medicines Corporation | $56.32 | 2021-2022 | |
| Genmab U.S., INC. | $55.70 | 2024-2025 | Epkinly |
| Taiho Oncology, INC. | $51.42 | 2025 | |
| Fennec Pharmaceuticals, INC. | $49.50 | 2024-2025 | Pedmark, Fyarro |
| Servier Pharmaceuticals LLC | $43.08 | 2022 | |
| Syndax Pharmaceuticals, INC. | $43.05 | 2025 | |
| Amneal Pharmaceuticals LLC | $42.33 | 2023-2024 | Neulasta, Neupogen, Avastin |
| Recordati_rare_diseases_inc. | $41.78 | 2023-2024 | Sylvant |
| Sumitomo Pharma America, INC. | $40.61 | 2023-2025 | Orgovyx |
| Organogenesis INC. | $39.91 | 2023 | Puraply |
| Chiesi USA, INC. | $36.24 | 2023-2024 | Ferriprox |
| Rigel Pharmaceuticals, INC. | $35.54 | 2025 | Gavreto, Tavalisse, Rezlidhia |
| Jazz Pharmaceuticals INC. | $32.99 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $31.39 | 2023-2025 | Sancuso |
| Tersera Therapeutics LLC | $27.14 | 2023 | Zoladex |
| Springworks Therapeutics, INC. | $26.14 | 2024 | Ogsiveo |
| Pharmacosmos Therapeutics INC. | $25.79 | 2022 | |
| Kite Pharma, INC. | $25.48 | 2021 | |
| Acrotech Biopharma INC. | $23.68 | 2024 | Beleodaq |
| Immunogen, INC. | $22.66 | 2023 | Elahere |
| Tg Therapeutics, INC. | $20.89 | 2022 | |
| Adaptive Biotechnologies Corporation | $19.84 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $18.07 | 2025 | Akynzeo |
| Foundation Medicine, INC. | $18.05 | 2021 | |
| Dova Pharmaceuticals | $16.03 | 2021 | |
| Immunocore Limited | $15.67 | 2025 | Kimmtrak |
| Pharmaessentia USA Corporation | $14.27 | 2025 | Besremi |
Drugs and devices associated with these payments
Kisqali $2,458Enhertu $658Imbruvica $620Libtayo $446Brukinsa $413Lenvima $382Keytruda $368Darzalex $355Epkinly $353Trodelvy $316Reblozyl $305Opdivo $303Monjuvi $285Somatuline Depot $284Onivyde $284Calquence $272Pemazyre $238Pluvicto $238Jaypirca $224Verzenio $224Gilotrif $205Udenyca $202Nubeqa $199Xpovio $197Jakafi $192Phesgo $177Cabometyx $170Opdualag $167Padcev $154Tecentriq $134Da Vinci Surgical System $131Tecvayli $122Adcetris $120Ultomiris $111Lutathera $108Nerlynx $107Fruzaqla $99.87Welireg $93.57Lynparza $93.01Pomalyst $91.84Tukysa $91.53Mektovi $88.49Braftovi $88.49Sarclisa $88.06Itovebi $85.32Elrexfio $78.81Xofigo $78.44Ibrance $77.21Rybrevant $73.51Elahere $72.51Inlyta $70.15Perjeta $68.25Promacta $67.32Orgovyx $66.48Amtagvi $65.20Vonjo $64.18Synagis $64.16Poteligeo $63.56Venclexta $63.46Polivy $63.34Mekinist $60.72Datroway $57.03Herceptin $54.42Xtandi $54.08Loqtorzi $52.40Inqovi $51.42Lonsurf $51.42Elzonris $50.29Bavencio $47.98Bosulif $46.28Elitek $44.03Neupogen $42.33Neulasta $42.33Avastin $42.33Sylvant $41.78Lupron Depot $41.11Lorbrena $40.30Puraply $39.91Carvykti $39.82Talvey $39.26Ferriprox $36.24Ninlaro $35.67Gavreto $35.54Rezlidhia $35.54Tavalisse $35.54Jevtana $33.45Zepzelca $32.99Iclusig $32.18Sancuso $31.39Ontruzant $30.99Dysport $30.69Fabhalta $29.94Vyloy $29.11Fotivda $28.62Zoladex $27.14Ogsiveo $26.14Piqray $25.20Pedmark $24.87Fyarro $24.63Alecensa $24.22
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.